|View printer-friendly version|
|CytomX to Present at the Jefferies 2015 Global Healthcare Conference|
SOUTH SAN FRANCISCO, Calif., May 28, 2015 – CytomX, a biotechnology company developing Probody™ therapeutics for the treatment of cancer, today announced that Sean McCarthy, D. Phil., chief executive officer, will present at the upcoming Jefferies 2015 Global Healthcare Conference in New York at 2:30 p.m. EDT on Tuesday, June 2, 2015. Dr. McCarthy will provide an overview of CytomX’s Probody™ pipeline, including the company’s Precision cancer immunotherapy and Probody drug conjugate programs.